福安药业：长效生长激素研发项目系重庆庆余堂参股公司的在研项目，属于创新药

Group 1 - The company's long-acting growth hormone is classified as an innovative drug, but it is not a first-class chemical drug [2] - The research project for the long-acting growth hormone is being developed by Suzhou Younuojin, a company in which the company's subsidiary, Chongqing Qingyutang, holds a stake [2] - The company clarified that it is not the main entity leading the research and development of this innovative drug project [2]